Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Summary
The main purpose of this study is to evaluate the efficacy and safety of HRS-4729 Injection in participants with type 2 diabetes who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin.
Official title: A Phase II, Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group Clinical Trial Evaluating the Efficacy and Safety of HRS-4729 Injection in Participants With Type 2 Diabetes
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2026-10
Completion Date
2027-07
Last Updated
2026-09-28
Healthy Volunteers
No
Conditions
Interventions
HRS-4729 Injection
HRS-4729 Injection
Mazdutide
Mazdutide
Placebo
Placebo
Locations (2)
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China
Tianjin Medical University Chu Hsien-I Memorial Hospital
Tianjin, Tianjin Municipality, China